Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
Metabolic Brain Disease|October 23, 2012
Parkinsonism in cirrhosis: pathogenesis and current therapeutic optionsRoger F ButterworthFrontiers in Neuroscience|March 27, 2023
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2Roger F ButterworthJournal of Clinical and Experimental Hepatology|June 5, 2015
Reprint of: Nutrition in the Management of Cirrhosis and its Neurological ComplicationsChantal Bémeur, Roger F ButterworthJournal of Clinical and Experimental Hepatology|March 11, 2015
Nutrition in the management of cirrhosis and its neurological complicationsChantal Bémeur, Roger F ButterworthDigestive Diseases (Basel, Switzerland)|July 18, 2018
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver DiseaseRoger F Butterworth, Ali CanbayNeurochemistry International|May 22, 2002
The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disordersPaul Desjardins, Roger F ButterworthMetabolic Brain Disease|December 6, 2012
Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edemaChantal Bémeur, Roger F ButterworthMetabolic Brain Disease|December 31, 2005
Acute liver failure: a critical appraisal of available animal modelsMireille Bélanger, Roger F ButterworthMetabolic Brain Disease|December 31, 2005
Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathySamir Ahboucha, Roger F ButterworthNeurological Research|January 5, 2008
Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventionsJavier Vaquero, Roger F ButterworthPageof 12